Search Results

Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the first quarter ending March 31, 2024.

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions.

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024.

Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that Jan De Witte has informed the Board of Directors of his intention to retire from his position as president and chief executive officer of Integra following the appointment of a successor, which the Company expects to occur by the end of 2024.

Integra LifeSciences Holdings Corporation reported financial results for the fourth quarter and full year ended December 31, 2023.

Integra LifeSciences Holdings Corporation is pleased to announce that following a successful Q1 2024 U.S. relaunch of its CereLink® ICP Monitoring System, the innovative product will be featured at the upcoming AANS Annual Scientific Meeting from May 3 through 6, 2024, in Chicago, Illinois.